2005
DOI: 10.1016/j.bmcl.2004.12.044
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
16
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 14 publications
0
16
0
Order By: Relevance
“…ethyl 3-(3-ethoxy-3-oxopropyl)-4-oxopiperidine-1-carboxylate, (6), following a literature procedure (Shah et al, 2005), which was converted in a three-step synthesis (68% yield) to thiolactam (8-1) (see Scheme 3).…”
Section: Resultsmentioning
confidence: 99%
“…ethyl 3-(3-ethoxy-3-oxopropyl)-4-oxopiperidine-1-carboxylate, (6), following a literature procedure (Shah et al, 2005), which was converted in a three-step synthesis (68% yield) to thiolactam (8-1) (see Scheme 3).…”
Section: Resultsmentioning
confidence: 99%
“…The structure of 58 was assigned by x-ray analysis of its hydrochloride salt 20. Significantly, the heterocyclic scaffolds present in 57 and 58 are found in compounds that are chemokine CCR5 receptor antagonists37 and inhibitors of dipeptidyl peptidase IV (DPP-IV) 38. Of course, 56 and related compounds may be transformed by other dipolar cycloaddition reactions, and such efforts are in progress.…”
Section: Resultsmentioning
confidence: 99%
“…For example, the octahydro-1H-pyrrolo[3,2- c ]pyridine scaffold present in 2 is represented in the CCR5 antagonist 3 14 and the bradykinin receptor antagonist martinellic acid ( 4 ). 15 Moreover, the privileged 2-arylpiperidine substructure present in 1 and 2 can be found in the substance P antagonist 5 16 and the neurokinin 1 receptor antagonist 6 .…”
Section: Introductionmentioning
confidence: 99%